Invention Grant
- Patent Title: Combretastatin analogs for use in the treatment of cancer
- Patent Title (中): Combretastatin类似物用于治疗癌症
-
Application No.: US13695804Application Date: 2011-05-05
-
Publication No.: US08980933B2Publication Date: 2015-03-17
- Inventor: Rainer Schobert , Bernhard Biersack , Thomas Müller
- Applicant: Rainer Schobert , Bernhard Biersack , Thomas Müller
- Applicant Address: DE Bayreuth DE Halle
- Assignee: Universitat Bayreuth,Martin-Luther-Universitat Halle-Wittenberg
- Current Assignee: Universitat Bayreuth,Martin-Luther-Universitat Halle-Wittenberg
- Current Assignee Address: DE Bayreuth DE Halle
- Agency: Foley & Lardner LLP
- Priority: EP10161990 20100505
- International Application: PCT/EP2011/057234 WO 20110505
- International Announcement: WO2011/138409 WO 20111110
- Main IPC: A61K31/4164
- IPC: A61K31/4164 ; A61K31/4178 ; A61K31/42 ; C07D233/64 ; C07D263/32 ; C07D403/04 ; A61K45/06 ; A61N5/10 ; C07D233/58 ; C07D403/10
Abstract:
The present invention relates to specific analogs of combretastatin, in particular the compounds of formula (I) as described and defined herein, and pharmaceutical compositions comprising the compounds, as well as their medical use, in particular in the treatment or prevention of cancer, including multidrug-resistant cancer.
Public/Granted literature
- US20130137740A1 COMBRETASTATIN ANALOGS FOR USE IN THE TREATMENT OF CANCER Public/Granted day:2013-05-30
Information query
